Clinical Omics – News and Features

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.

A liquid biopsy that measures DNA methylation has predicted early disease progression and potential survival in breast cancer patients.

In this article, we take a deep dive into the world of epigenetic aging clocks, finding out what they are, what they can tell us and how they might be applied in future.

The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.

Around 5,500 people with severe developmental disorders now know the genetic cause of their condition, thanks to a major nationwide study which will help improve diagnosis across the world.

This article will review the latest applications of mass spectrometry-based techniques across the stages of biopharmaceutical development and testing.

A team of biomedical engineers has been working to make LC-MS/MS sample preparation simpler and much more automated, a key ingredient to the technique being widely adopted by clinicians.

This article discusses how library-based approaches in quantitative proteomics can increase the sensitivity and accuracy of such detection systems.

Researchers have published an assessment of 13 studies that took a genotype-first approach to patient care that contrasts with the typical phenotype-first approach to clinical research, which starts with clinical findings.